Sullivan AM - Search Results

1

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease.

Costello DJ, O'Keeffe GW, Hurley FM, Sullivan AM. Costello DJ, et al. Among authors: sullivan am. J Cell Mol Med. 2012 Oct;16(10):2451-60. doi: 10.1111/j.1582-4934.2012.01562.x. J Cell Mol Med. 2012. PMID: 22436046 Free PMC article.

2

Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease.

Hurley FM, Costello DJ, Sullivan AM. Hurley FM, et al. Among authors: sullivan am. Exp Neurol. 2004 Feb;185(2):281-9. doi: 10.1016/j.expneurol.2003.10.003. Exp Neurol. 2004. PMID: 14736509

3

Expression of growth differentiation factor-5 in the developing and adult rat brain.

O'Keeffe GW, Hanke M, Pohl J, Sullivan AM. O'Keeffe GW, et al. Among authors: sullivan am. Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):199-202. doi: 10.1016/j.devbrainres.2004.04.004. Brain Res Dev Brain Res. 2004. PMID: 15246706

4

Donor age affects differentiation of rat ventral mesencephalic stem cells.

O' Keeffe GW, Sullivan AM. O' Keeffe GW, et al. Among authors: sullivan am. Neurosci Lett. 2005 Feb 28;375(2):101-6. doi: 10.1016/j.neulet.2004.10.083. Epub 2004 Nov 30. Neurosci Lett. 2005. PMID: 15670650

5

Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.

Wood TK, McDermott KW, Sullivan AM. Wood TK, et al. Among authors: sullivan am. J Neurosci Res. 2005 Jun 15;80(6):759-66. doi: 10.1002/jnr.20507. J Neurosci Res. 2005. PMID: 15880784

6

Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro.

O'Keeffe GW, Dockery P, Sullivan AM. O'Keeffe GW, et al. Among authors: sullivan am. J Neurocytol. 2004 Sep;33(5):479-88. doi: 10.1007/s11068-004-0511-y. J Neurocytol. 2004. PMID: 15906156

7

The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Sullivan AM, O'Keeffe GW. Sullivan AM, et al. J Anat. 2005 Sep;207(3):219-26. doi: 10.1111/j.1469-7580.2005.00447.x. J Anat. 2005. PMID: 16185246 Free PMC article. Review.

8

Differential effects of GDF5 on the medial and lateral rat ventral mesencephalon.

Clayton KB, Sullivan AM. Clayton KB, et al. Among authors: sullivan am. Neurosci Lett. 2007 Nov 12;427(3):132-7. doi: 10.1016/j.neulet.2007.09.025. Epub 2007 Sep 20. Neurosci Lett. 2007. PMID: 17935884

9

Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.

Crotty S, Fitzgerald P, Tuohy E, Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y. Crotty S, et al. Among authors: sullivan am. Eur J Neurosci. 2008 Jan;27(2):294-300. doi: 10.1111/j.1460-9568.2007.06018.x. Epub 2008 Jan 11. Eur J Neurosci. 2008. PMID: 18190522

10

TAT-PAX6 protein transduction in neural progenitor cells: a novel approach for generation of dopaminergic neurones in vitro.

Spitere K, Toulouse A, O'Sullivan DB, Sullivan AM. Spitere K, et al. Among authors: sullivan am. Brain Res. 2008 May 7;1208:25-34. doi: 10.1016/j.brainres.2008.02.065. Epub 2008 Mar 4. Brain Res. 2008. PMID: 18387597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters